The 2016 Boulder Peptide Symposium once again brings together thought leaders in biotech, pharma, and academic institutions to present current paradigms in peptide therapeutics and to uncover solutions to challenges in peptide drug discovery and development. The symposium program includes a one day retreat for intensive one-to one meetings, workshops and networking.
Peptide Showcase- continued
Award for Best Peptide Showcase Presentation
Peptides in the Clinic
Transfer to Red Lion and Lunch
Workshop: Academic-Industry Partnerships
1-1 Meetings and Networking Break
Gala Dinner at the Red Lion Inn and Transfer to St Julien
Peptides in the Clinic -continued
Meienhofer Award Address - Richard DiMarchi
Chemistry and Analytics
Lunch and Farewell Reception
ABOUT THE BOULDER PEPTIDE SYMPOSIUM
The Boulder Peptide Symposium seeks to bring together key decision leaders from both industry and academia to discuss the future of peptide therapeutics. Peptide therapeutics are potent and highly selective yet their development into effective treatments can be challenged by limited delivery routes, product stability, manufacturing challenges and an evolving regulatory landscape. BPS is the key forum where these challenges will be identified, discussed, and one day—addressed.